HLA-DRB1*15:01 has also been reported to be associated with the extent of demyelination in younger MS cases and higher T2 lesion load, resulting in decreased brain volume and cognitive performance [122,123], but overall, no strong contributions of HLA alleles to disease severity or clinical course have been found [120]. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.